lysophosphatidic acid has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abo El-Magd, NF; Eraky, SM; Ramadan, NM | 1 |
| Ban, KY; Jun, HS; Kim, D; Lee, GH | 1 |
| Choi, H; Jun, HS; Kim, D; Lee, JH; Sarker, MK; Shin, D | 1 |
| De Giorgio, R; He, P; Koval, M; Srinivasan, S; Weinman, EJ; Yun, CC; Zhao, L; Zhu, L | 1 |
| Abu El-Asrar, AM; Kangave, D; Mohammad, G; Nawaz, MI; Opdenakker, G; Siddiquei, MM | 1 |
| Kim, J; Lim, S; Park, HS; Park, KS; Ryu, SH; Suh, PG; Yea, K | 1 |
6 other study(ies) available for lysophosphatidic acid and Alloxan Diabetes
| Article | Year |
|---|---|
The ameliorative effect of bromelain on STZ-induced type 1 diabetes in rats through Oxi-LDL/LPA/LPAR1 pathway.
Topics: Animals; Bromelains; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Lipoproteins, LDL; Lysophospholipids; Male; Metabolic Networks and Pathways; Rats; Receptors, Lysophosphatidic Acid; Streptozocin | 2021 |
Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Early Growth Response Protein 1; Enhancer of Zeste Homolog 2 Protein; Histones; Inflammasomes; Inflammation; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Pyroptosis | 2023 |
Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Topics: Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Kidney Glomerulus; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Phenylacetates; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Transcription Factor RelA | 2019 |
Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss.
Topics: Adenosylhomocysteinase; Animals; Caco-2 Cells; Diabetes Complications; Diabetes Mellitus, Experimental; Diarrhea; Humans; Intestinal Mucosa; Intestines; Lectins, C-Type; Lysophospholipids; Membrane Proteins; Mice; Mice, Knockout; Microvilli; Phosphoproteins; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers | 2015 |
Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Female; Humans; Lysophospholipids; Male; Middle Aged; Phosphoric Diester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vitreous Body; Young Adult | 2013 |
Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Blood Glucose; Cell Membrane; Chromones; Diabetes Mellitus, Experimental; Down-Regulation; Glucose; Glucose Transporter Type 4; GTP-Binding Protein alpha Subunits, Gi-Go; Insulin; Isoxazoles; Lysophospholipids; Male; Mice; Mice, Inbred ICR; Morpholines; Muscle Fibers, Skeletal; Pertussis Toxin; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Propionates; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid | 2008 |